These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE). Silva M; Poo J; Wagner F; Jackson M; Cutler D; Grace M; Bordens R; Cullen C; Harvey J; Laughlin M J Hepatol; 2006 Aug; 45(2):204-13. PubMed ID: 16780997 [TBL] [Abstract][Full Text] [Related]
4. Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction. Keeffe EB Semin Liver Dis; 2003; 23 Suppl 1():1-2. PubMed ID: 12934161 [No Abstract] [Full Text] [Related]
5. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Fried MW; Hadziyannis SJ Semin Liver Dis; 2004; 24 Suppl 2():47-54. PubMed ID: 15346246 [TBL] [Abstract][Full Text] [Related]
6. Weight-based versus fixed dosing of peginterferon (40kDa) alfa-2a. Lamb MW; Martin NE Ann Pharmacother; 2002 May; 36(5):933-5. PubMed ID: 12014351 [No Abstract] [Full Text] [Related]
7. Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C. van der Eijk AA; Vrolijk JM; Haagmans BL N Engl J Med; 2006 Mar; 354(12):1323-4. PubMed ID: 16554542 [No Abstract] [Full Text] [Related]
8. [Has hepatitis C become curable by a new pegylated interferon?]. Trépo C; Merle P Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851 [No Abstract] [Full Text] [Related]
15. [Pegylated alfa-2a in hepatitis B. Fewer injections with better results?]. MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725009 [No Abstract] [Full Text] [Related]
16. [Therapy of chronic hepatitis C with pegylated interferon alfa-2a]. Berg T Z Gastroenterol; 2001 Jul; 39(7):551-4. PubMed ID: 11505337 [No Abstract] [Full Text] [Related]
17. Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD). Reddy KR Semin Liver Dis; 2004; 24 Suppl 2():33-8. PubMed ID: 15346244 [TBL] [Abstract][Full Text] [Related]
18. [High dose of pegylated interferon alpha-2a for the treatment of genotype1 chronic hepatitis C: a case report]. Wu CH; Wang LF; Xu XY Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):873. PubMed ID: 21138646 [No Abstract] [Full Text] [Related]
19. Pegylated IFNs for chronic hepatitis C: an update. Grace MJ; Cutler DL; Bordens RW Expert Opin Drug Deliv; 2005 Mar; 2(2):219-26. PubMed ID: 16296749 [TBL] [Abstract][Full Text] [Related]
20. [Pegylated interferon sets a new standard. Better prognosis for hepatitis C infected patients]. MMW Fortschr Med; 2002 May; 144(21):56. PubMed ID: 12138886 [No Abstract] [Full Text] [Related] [Next] [New Search]